Revenue
No reported data
Accustem Sciences Inc. (ACUT)
Price—Loading quote
Net income
2021
2022
2023
2024
2025
Free cash flow
2022
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Research & development | $281,014 | $138,324 | $139,663 | $266,933 | $73,335 |
| Operating expenses | $1.8M | $1.5M | $2.1M | $3.7M | $670,614 |
| Operating income | −$1.8M | −$1.5M | −$2.1M | −$3.7M | −$670,614 |
| Net income | −$1.8M | −$1.5M | −$2.1M | −$3.7M | −$670,614 |
| Basic EPSper diluted share | -$0.12 | -$0.13 | -$0.18 | -$0.34 | -$0.07 |
| Diluted EPSper diluted share | -$0.12 | -$0.13 | -$0.18 | -$0.34 | — |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 13, 2025Form 4 | CERRONE GABRIELE MDirector,TenPercentOwner | BuyCommon Stock · indirect | 400 | $1.10 | $440.00 | 6.50M |
| Jun 13, 2025Form 4 | CERRONE GABRIELE MDirector,TenPercentOwner | BuyCommon Stock · indirect | 2.0K | $1.00 | $2.0K | 6.50M |
| Jun 12, 2025Form 4 | CERRONE GABRIELE MDirector,TenPercentOwner | BuyCommon Stock · indirect | 9.0K | $0.83 | $7.5K | 6.50M |
| Jun 11, 2025Form 4 | CERRONE GABRIELE MDirector,TenPercentOwner | BuyCommon Stock · indirect | 28.2K | $0.39 | $11.0K | 6.49M |
| Apr 9, 2025Form 4 | CERRONE GABRIELE MDirector,TenPercentOwner | BuyCommon Stock · indirect | 3.0K | $0.67 | $2.0K | 4.91M |